Lataa...
Sofosbuvir/velpatasvir: A promising combination
Hepatitis C virus (HCV) affects 3% of the world population. It represents the main cause of chronic liver disease and is responsible for extra-hepatic complications, such as type 2 diabetes and cardiovascular diseases. HCV includes 7 genotypes differing in the nucleotide sequence variability, the ge...
Tallennettuna:
| Julkaisussa: | World J Hepatol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937166/ https://ncbi.nlm.nih.gov/pubmed/27429714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v8.i19.785 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|